NASP Member EVERSANA’s Data & Analytics platform to be used by ICER to conduct indirect treatment comparisons to support value assessments
Jul 23, 2020 · NASP News
CHICAGO – July 23, 2020 – EVERSANA™, the leading provider of global commercial services to the life sciences industry, today announced a partnership with the Institute for Clinical and Economic Review (ICER) to advance standards for the usage of transparent, replicable and robust indirect treatment comparisons in health technology assessments.